Probenecid Improves Cardiac Function in Subjects with a Fontan Circulation and Augments Cardiomyocyte Calcium Homeostasis-Reference-Cited by-同舟云学术

Probenecid Improves Cardiac Function in Subjects with a Fontan Circulation and Augments Cardiomyocyte Calcium Homeostasis

Published:2020-08-07 Issue:8 Volume:41 Page:1675-1688
ISSN:0172-0643
Container-title:Pediatric Cardiology
language:en
Short-container-title:Pediatr Cardiol

Author:

Rubinstein Jack^ORCID,Woo Jessica G.,Garcia Anastacia M.,Alsaied Tarek,Li Jia,Lunde Per Kristian,Moore Ryan A.,Laasmaa Martin,Sammons Amanda,Mays Wayne A.,Miyamoto Shelley D.,Louch William E.,Veldtman Gruschen R.

Funder

American Heart Association

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology, and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s00246-020-02427-7.pdf

Reference44 articles.

1. Robbins N, Koch SE, Tranter M, Rubinstein J (2012) The history and future of probenecid. Cardiovasc Toxicol 12:1–9. https://doi.org/10.1007/s12012-011-9145-8

2. Sowunmi A, Fehintola FA, Adedeji AA et al (2004) Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Trop Med Int Health 9:606–614. https://doi.org/10.1111/j.1365-3156.2004.01233.x

3. Koch SE, Tranter M, Robbins N et al (2013) Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model. J Cardiovasc Pharmacol Ther 18:280–289. https://doi.org/10.1177/1074248412469299

4. Koch SE, Gao X, Haar L et al (2012) Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. J Mol Cell Cardiol 53:134–144. https://doi.org/10.1016/j.yjmcc.2012.04.011

5. Robbins N, Gilbert M, Kumar M et al (2018) Probenecid improves cardiac function in patients with heart failure with reduced ejection fraction in vivo and cardiomyocyte calcium sensitivity in vitro. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.007148

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Hyperuricemia and Urate-Lowering Agents on Cardiovascular Diseases;Clinical Medicine Insights: Cardiology;2024-01

2. Polyarginine Cell-Penetrating Peptides Bind and Inhibit SERCA2;Cells;2023-09-26

3. Advances in pharmacotherapies for hyperuricemia;Expert Opinion on Pharmacotherapy;2023-03-30

4. Drug repurposing for cardiovascular diseases: New targets and indications for probenecid;British Journal of Pharmacology;2022-12-26

5. Repurposing Probenecid for the Treatment of Heart Failure (Re-Prosper-HF): a study protocol for a randomized placebo-controlled clinical trial;Trials;2022-04-07